The largest database of trusted experimental protocols

Ultralink protein a g beads

Manufactured by Thermo Fisher Scientific
Sourced in United States

Ultralink Protein A/G Beads are agarose-based affinity beads designed for the purification of immunoglobulins and other Fc-containing proteins. The beads feature a covalently coupled Protein A/G ligand, which binds to the Fc region of antibodies with high affinity. This allows for the efficient capture and purification of antibodies from complex samples.

Automatically generated - may contain errors

4 protocols using ultralink protein a g beads

1

Luciferase Immunoprecipitation for NS3 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Luciferase immunoprecipitation system (LIPS) was performed as previously described [12 (link)]. Serum samples were diluted 1:10 in buffer A (50 mN Tris [pH 7.5], 100 mM NaCl, 5 mM MGCL2, and 1% Triton X-100). 1 × 107 relative light units (RLU) of a Renilla-luciferase-NS3-antigen fusion (RLUC-NS3) was mixed into 40 μL buffer A and subsequently added to 10 μL of diluted sera for 1 h shaking at room temperature. For antigen precipitation: 30% Ultralink protein A/G beads (Pierce Biotechnology, Rockford, IL) were added to a 96-well filter HTS plate (Millipore, Bedford, MA), before 100 μL of the RLUC-NS3 antigen serum mixture was added for 1 h shaking at RT. Afterwards the filter plate was washed on a vacuum plate washer. Antigen-precipitation was quantified by adding 100 μL coelenterazine (p.j.k. GmbH, Kleinblittersdorf, Germany) on a Berthold LB960 centro XS3 plate luminometer (Berthold, Freiburg). The threshold for NS3-antibody positive samples was set at three standard deviations above the average of the negative controls.
+ Open protocol
+ Expand
2

Quantification of Anti-EqHV NS3 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-EqHV NS3 antibodies were semi-quantitatively measured by luciferase immunoprecipitation system (LIPS) as previously described (27 (link)). Serum samples diluted 1:10 in buffer A (50 mM Tris [pH 7.5], 100 mM NaCl, 5 mM MGCL2, and 1% Triton X-100) were measured in duplicates. Luciferase-NS3 fusion antigen (107 relative light units) was mixed in 40 μL buffer A and then added to 10 μL of diluted sera. The mixture was shaken at room temperature for 1 h. Antigen was precipitated using 30% Ultralink protein A/G beads (Pierce Biotechnology, Rockford, IL) added to a 96-well filter HTS plate (Millipore, Bedford, MA). Afterwards, 100 μL of the RLUC-NS3 antigen serum mixture was added and incubated for 1 h shaking at room temperature. The filter plate was then washed with phosphate-buffered saline on a vacuum plate washer. Antigen-precipitation was quantified by adding 100 μL coelenterazine (PJK GmbH, Kleinblittersdorf, Germany) on a Berthold LB960 Centro XS3 plate luminometer (Berthold, Freiburg, Germany). The threshold for NS3-antibody positive samples was set at three standard deviations above the average of the negative controls.
+ Open protocol
+ Expand
3

Quantification of Anti-EqHV NS3 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-EqHV NS3 antibodies were semi-quantitatively measured by luciferase immunoprecipitation system (LIPS) as previously described (27 (link)). Serum samples diluted 1:10 in buffer A (50 mM Tris [pH 7.5], 100 mM NaCl, 5 mM MGCL2, and 1% Triton X-100) were measured in duplicates. Luciferase-NS3 fusion antigen (107 relative light units) was mixed in 40 μL buffer A and then added to 10 μL of diluted sera. The mixture was shaken at room temperature for 1 h. Antigen was precipitated using 30% Ultralink protein A/G beads (Pierce Biotechnology, Rockford, IL) added to a 96-well filter HTS plate (Millipore, Bedford, MA). Afterwards, 100 μL of the RLUC-NS3 antigen serum mixture was added and incubated for 1 h shaking at room temperature. The filter plate was then washed with phosphate-buffered saline on a vacuum plate washer. Antigen-precipitation was quantified by adding 100 μL coelenterazine (PJK GmbH, Kleinblittersdorf, Germany) on a Berthold LB960 Centro XS3 plate luminometer (Berthold, Freiburg, Germany). The threshold for NS3-antibody positive samples was set at three standard deviations above the average of the negative controls.
+ Open protocol
+ Expand
4

High-throughput Luciferase Immunoprecipitation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Essentially as described, the LIPS assays were performed in approximately 2.5 h using a 96-well plate format at room temperature [19 (link),20 (link),21 (link)]. Briefly, recombinant luciferase antigen lysates were produced from transfection of DNA plasmids constructs into Cos1 cells and their activity in light units (LU) was determined with a tube luminometer (Turner Design 20/20). To initiate testing, 40 μL of buffer A, 10 μL of diluted human sera (1 μL equivalent), and the luciferase-antigen cell extract (input of approximately 10 million LU), diluted in buffer A, were added to each well of a microtiter plate for 1 h. Next, a 30% suspension (6 μL) of Ultralink protein A/G beads (Pierce Biotechnology, Rockford, IL, USA) was added to the bottom of each well of a 96-well filter HTS plate (Millipore, Bedford, MA, USA). The 100 μL antigen-antibody reaction mixture was moved to a filter plate and incubated for 1 h on a rotary shaker. Multiple washing steps of the retained protein A/G beads were then performed. After completion of the washing steps, LU were measured in a Berthold LB 960 Centro microplate luminometer (Berthold Technologies, Bad Wildbad, Germany) using either coelenterazine or furimazine substrate (Promega, Madison, WI, USA) for detecting Renilla luciferase and NanoLuc activity, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!